Gulf pharmaceutical supply chain

The U.S.-Israeli war with Iran is disrupting pharmaceutical air routes into the Gulf, forcing drugmakers to reroute temperature-sensitive shipments and raising the risk of shortages of cancer medicines and other critical treatments if the conflict continues.